TOTAL: {[ getCartTotalCost() | currencyFilter ]} Update cart for total shopping_basket Checkout

Daily Dashboard | FTC’s enforcement reversal could spur more legal action with LabMD Related reading: White House, industry reveal more details on US privacy framework

rss_feed
PSR18_Web_300x250-COPY
DPC18_Web_300x250-COPY

LabMD “will likely” challenge the Federal Trade Commission’s recent decision against it, Bloomberg BNA reports. That ruling said consumers did not have to experience tangible harm in order to trigger a complaint under the FTC Act. Rather, a company’s “lax security” is suitable grounds for an enforcement action, the report states. The ruling “may … influence other legal proceedings where the inability of plaintiffs to demonstrate harm resulting from a data breach of their personal information has been a leading reason for dismissal of their actions,” the report adds. “I'm trying to protect other companies from the FTC,” said LabMD CEO Michael Daugherty.
Full Story

Comments

If you want to comment on this post, you need to login.